BIO-CEO Wraps Up 19th Annual Investor Conference
Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded […]
feature2
SafeHeal Medical’s Solution to Reshape Digestive Surgery
SafeHeal Medical is a company developing a breakthrough solution for patients undergoing colorectal surgery. Its product, the SafeHeal Colovac device, eliminates the traditional need for […]
Catalia Health’s Healthcare Robot Improves Patient Outcomes
Catalia Health, a San Francisco-based company, is garnering attention from the medtech industry with its healthcare robot. The “Mabu” is a personal healthcare companion aimed at […]
Industry Leaders Outlook on the Future of Healthcare
BY: BRETT JOHNSON, EDITOR-IN-CHIEF “Value-driven” vs. “volume-driven” was the theme of a discussion between top management of the country’s important healthcare institutions. Leaders of Mayo Clinic, […]
Progress on Antibe’s Non-Steroidal Anti-Inflammatory Drug
Results of additional testing have been recently announced by Antibe Therapeutics pertaining to the progress of the developmental procedures being conducted by the company for […]
Wafergen’s Smartchip Mydesign Genomic Technology to be Employed by Procter & Gamble
Wafergen Biosystems and Procter & Gamble recently announced their industrial partnership that involves the latter utilizing the former’s specialized quantitative PCR System namely SmartChip MyDesign. […]
Cellular Biomedicine Group Joins Force With Huntsworth Health For KOL Advocacy On Clinical Research For Knee Osteoarthritis
Cellular Biomedicine Group, Inc. (CBMG) has took on Hunstworth Health to put in order a team of medical experts for a global KOL advocacy campaign […]
Capnia Develop Cluster Headache Medicine with Partner Clinvest
A recently announced Memorandum of Understanding (MOU) between Capnia, Inc. and Clinvest, a Banyan Group, Inc. division, has brought about the formation of the collaboration […]
Aeolus Pharma’s AEOL 10150 Declared Orphan Drug for IPF and Lung-ARS
The US FDA recently announced that the experimental drug being developed by Aeolus Pharmaceuticals, Inc. AEOL 10150 has been granted the Orphan Drug status. This […]
Cavendish Global Health Impact Forum
Cavendish Global 
uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences. For more information about Cavendish Global email info@onemedmarket,com. Cavendish will be attending OneMedForum in San Francisco and will be available for meetings.